+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotechnology Contract Manufacturing Market by Service (Manufacturing, Fill Finish, Packaging), Type (Drug Substance, Drug Product), Scale, Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecasts to 2028

  • PDF Icon

    Report

  • 324 Pages
  • September 2023
  • Region: Global
  • Markets and Markets
  • ID: 5879692
Description Jump to:

Europe is Second Largest Region in the Biotechnology Contract Manufacturing Market

The biotechnology contract manufacturing market is estimated to reach USD 24.8 billion by 2028 from USD 16.6 billion in 2023, at a CAGR of 8.3% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing partnerships and collaborations between pharmaceutical companies and biologics contract manufacturers. For instance, In January 2023, Catalent (US) entered into an agreement with Sarepta Therapeutics, Inc. (US) for manufacturing of Sarepta’s most advanced gene therapy candidate, delandistrogene moxeparvovec (SRP-9001) for the treatment of Duchenne muscular dystrophy. Similarly, In December 2022, Merck KGaA (Germany) and Synplogen (Japan) entered into an agreement to accelerate the development and manufacturing of viral vector-based gene therapy applications.

The monoclonal antibodies segment accounted for the largest share by molecule type during the forecast period.

In 2022, the monoclonal antibodies segment accounted for the largest share by molecules in the global biotechnology contract manufacturing market. The large share of this segment is attributed to the rising prevalence of diseases, increasing government initiatives for the development of monoclonal antibody drugs, and the growing number of mAb product candidates currently in the clinical pipeline.

Europe: The second largest region in the biotechnology contract manufacturing market

Europe accounted for the second-largest market for biotechnology contract manufacturing market after North America. The European biotechnology contract manufacturing market has experienced substantial growth in recent years, driven by various factors such as increasing investments for the development of biologics such as monoclonal antibodies and cell & gene therapies and biomanufacturing capacity expansions. Europe is at the forefront of developing and adopting emerging technologies in the field of biotechnology contract manufacturing market. In March 2023, Lonza completed its cGMP clinical and commercial manufacturing site, which is dedicated to large-scale commercial drug product manufacturing.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side - 70% and Demand Side - 30%
  • By Designation: Managers - 45%, CXO and Directors - 30%, and Executives - 25%
  • By Region: North America - 40%, Europe - 25%, Asia-Pacific - 20%, Latin America - 10% and Middle East & Africa - 5%

Research Coverage:

This report provides a detailed picture of the biotechnology contract manufacturing market. It aims to estimate the size and future growth potential of the market across different segments such as the service, type, scale of operation, source, molecule type, therapeutic area, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing demand for biologics & biosimilars, Increased biologics outsourcing trend among biopharmaceutical companies, Increased focus on personalized medicine, Increasing partnerships and collaborations between pharmaceutical companies and biologics CDMOs), restraints (intellectual property rights issues), opportunities (Rising demand for cell & gene therapy, biologics contract manufacturing market expansions in emerging countries, expansion of biologics manufacturing capacities by CMOs, strong emphasis on drug development), and challenges (challenges to meet reformed regulations) influencing the growth of the market.
  • Service Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the biotechnology contract manufacturing market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the biotechnology contract manufacturing market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), Catalent, Inc. (US), WuXi Biologics (China), AbbVie, Inc. (US), and others in the market.

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition and Scope
1.2.1 Inclusions and Exclusions
1.2.2 Markets Covered
1.2.3 Years Considered
1.3 Currency
1.4 Stakeholders
1.5 Limitations
1.6 Recession Impact

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 2 Biotechnology Contract Manufacturing Market: Breakdown of Primaries
2.2 Market Size Estimation
Figure 3 Biotechnology Contract Manufacturing Industry Size Estimation (Supply-Side Analysis), 2022
Figure 4 Market Size Estimation: Approach 1 - Revenue Share Analysis, 2022
Figure 5 Illustrative Example of Thermo Fisher Scientific Inc.: Revenue Share Analysis, 2022
2.2.1 Insights from Primaries
Figure 6 Market Validation from Primary Experts
Figure 7 Market Size Estimation Methodology: Top-Down Approach
2.3 Growth Rate Assumptions/Growth Forecast
Figure 8 Market: CAGR Projections
Figure 9 Market: Growth Analysis of Drivers, Restraints, Challenges, and Opportunities
2.4 Market Breakdown and Data Triangulation
Figure 10 Data Triangulation Methodology
2.5 Research Assumptions
2.6 Risk Analysis
2.7 Recession Impact Analysis
Table 1 Global Inflation Rate Projections, 2021-2028 (% Growth)
Table 2 US Health Expenditure, 2019-2022 (USD Million)
Table 3 US Health Expenditure, 2023-2030 (USD Million)

3 Executive Summary
Figure 11 Biotechnology Contract Manufacturing Market, by Service, 2023 vs. 2028 (USD Million)
Figure 12 Market, by Type, 2023 vs. 2028 (USD Million)
Figure 13 Market, by Source, 2023 vs. 2028 (USD Million)
Figure 14 Geographical Snapshot of Biotechnology Contract Manufacturing Industry

4 Premium Insights
4.1 Biotechnology Contract Manufacturing Market Overview
Figure 15 Rising Approvals of Biologics to Drive Market
4.2 North America: Market Share, by Scale of Operation & Country (2022)
Figure 16 Commercial Operations Segment Accounted for Largest Share of North American Market in 2022
4.3 Market Share, by Therapeutic Area, 2023 vs. 2028
Figure 17 Oncology Segment Will Continue to Dominate Market in 2028
4.4 Market, by Molecule Type, 2023 vs. 2028 (USD Million)
Figure 18 Pharmaceutical Manufacturing Services Segment Will Continue to Dominate Market in 2028
4.5 Market: Geographic Growth Opportunities
Figure 19 Asia-Pacific Countries to Register Higher Growth During Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 20 Biotechnology Contract Manufacturing Market: Drivers, Restraints, Opportunities, and Challenges
Table 4 Biotechnology Contract Manufacturing Industry: Impact Analysis
5.2.1 Drivers
5.2.1.1 Rising Demand for Biologics and Biosimilars
Figure 21 Number of Approved Biologics, 2015-2022
Figure 22 US: Number of Approved and Launched Biosimilars, 2015-2022
5.2.1.2 Increasing Outsourcing of Biologics Manufacturing Among Biopharmaceutical Companies
5.2.1.3 Growing Focus on Personalized Medicine
Figure 23 Personalized Medicines (% of All Fda-Approved Drugs), 2015-2022
5.2.1.4 Increasing Collaborations Between Pharmaceutical Companies and Biologics Cmos
5.2.1.5 Advancements in Manufacturing Technologies
5.2.2 Restraints
5.2.2.1 Intellectual Property Rights Issues
5.2.3 Opportunities
5.2.3.1 Rising Demand for Cell and Gene Therapies
Table 5 List of Expansions by Top Companies
5.2.3.2 Significant Growth Opportunities Offered by Emerging Countries
5.2.3.3 Expansion of Biologics Manufacturing Capacities by Cmos
5.2.3.4 Strong Emphasis on Drug Development
Table 6 List of Key Biologics Facing Patent Expiry
5.2.4 Challenges
5.2.4.1 Complying with Regulatory Reforms
5.3 Value Chain Analysis
Figure 24 Value Chain Analysis of Market: Manufacturing and Distribution Phases ADD Maximum Value
5.4 Ecosystem Analysis
Figure 25 Ecosystem Analysis: Market
Table 7 Market: Role in Ecosystem
5.5 Porter's Five Forces Analysis
Table 8 Market: Porter's Five Forces Analysis
5.5.1 Threat of New Entrants
5.5.2 Threat of Substitutes
5.5.3 Bargaining Power of Suppliers
5.5.4 Bargaining Power of Buyers
5.5.5 Intensity of Competitive Rivalry
5.6 Technology Analysis
5.7 Regulatory Analysis
5.7.1 Regulatory Bodies, Government Agencies, and Other Organizations
Table 9 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 12 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 Regulatory Scenarios Across Different Countries/Regions
5.8 Key Conferences and Events in 2023-2024
Table 14 Market: Detailed List of Conferences and Events
5.9 Key Stakeholders and Buying Criteria
5.9.1 Key Stakeholders in the Buying Process
Figure 26 Influence of Stakeholders on the Buying Process of Biotechnology Cmo Services
5.9.2 Buying Criteria
Figure 27 Key Buying Criteria for End-users
5.10 Trends/Disruptions Impacting Customer's Business

6 Biotechnology Contract Manufacturing Market, by Service
6.1 Introduction
Table 15 Biotechnology Contract Manufacturing Industry, by Service, 2021-2028 (USD Million)
6.2 Manufacturing
6.2.1 Shift Toward Single-Use Technology to Drive Market
Table 16 Biotechnology Contract Manufacturing Services Market, by Region, 2021-2028 (USD Million)
Table 17 North America: Biotechnology Contract Manufacturing Services Market, by Country, 2021-2028 (USD Million)
Table 18 Europe: Biotechnology Contract Manufacturing Services Market, by Country, 2021-2028 (USD Million)
Table 19 Asia-Pacific: Biotechnology Contract Manufacturing Services Market, by Country, 2021-2028 (USD Million)
Table 20 Latin America: Biotechnology Contract Manufacturing Services Market, by Country, 2021-2028 (USD Million)
6.3 Formulation & Fill-Finish
6.3.1 Most Critical Aspect of Biologics Manufacturing
Table 21 Biotechnology Contract Formulation & Fill-Finish Services Market, by Region, 2021-2028 (USD Million)
Table 22 North America: Biotechnology Contract Formulation & Fill-Finish Services Market, by Country, 2021-2028 (USD Million)
Table 23 Europe: Biotechnology Contract Formulation & Fill-Finish Services Market, by Country, 2021-2028 (USD Million)
Table 24 Asia-Pacific: Biotechnology Contract Formulation & Fill-Finish Services Market, by Country, 2021-2028 (USD Million)
Table 25 Latin America: Biotechnology Contract Formulation & Fill-Finish Services Market, by Country, 2021-2028 (USD Million)
6.4 Packaging & Labeling
6.4.1 Final Checkpoint Before Product Reaches Patient
Table 26 Biotechnology Contract Packaging & Labeling Services Market, by Region, 2021-2028 (USD Million)
Table 27 North America: Biotechnology Contract Packaging & Labeling Services Market, by Country, 2021-2028 (USD Million)
Table 28 Europe: Biotechnology Contract Packaging & Labeling Services Market, by Country, 2021-2028 (USD Million)
Table 29 Asia-Pacific: Biotechnology Contract Packaging & Labeling Services Market, by Country, 2021-2028 (USD Million)
Table 30 Latin America: Biotechnology Contract Packaging & Labeling Services Market, by Country, 2021-2028 (USD Million)
6.5 Other Services
Table 31 Other Biotechnology Contract Manufacturing Services Market, by Region, 2021-2028 (USD Million)
Table 32 North America: Other Biotechnology Contract Manufacturing Services Market, by Country, 2021-2028 (USD Million)
Table 33 Europe: Other Biotechnology Contract Manufacturing Services Market, by Country, 2021-2028 (USD Million)
Table 34 Asia-Pacific: Other Biotechnology Contract Manufacturing Services Market, by Country, 2021-2028 (USD Million)
Table 35 Latin America: Other Biotechnology Contract Manufacturing Services Market, by Country, 2021-2028 (USD Million)

7 Biotechnology Contract Manufacturing Market, by Type
7.1 Introduction
Table 36 Market, by Type, 2021-2028 (USD Million)
7.2 Biologic Drug Substance Manufacturing
7.2.1 Increasing Demand for Biotechnology Products to Drive Market
Table 37 Biologic Drug Substance Manufacturing Market, by Region, 2021-2028 (USD Million)
Table 38 North America: Biologic Drug Substance Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 39 Europe: Biologic Drug Substance Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 40 Asia-Pacific: Biologic Drug Substance Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 41 Latin America: Biologic Drug Substance Manufacturing Market, by Country, 2021-2028 (USD Million)
7.3 Biologic Drug Product Manufacturing
7.3.1 Increasing R&D Cost and Process Complexity Prompted Shift Toward Contract Manufacturing for Biologic Drug Products
Table 42 Biologic Drug Product Manufacturing Market, by Region, 2021-2028 (USD Million)
Table 43 North America: Biologic Drug Product Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 44 Europe: Biologic Drug Product Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 45 Asia-Pacific: Biologic Drug Product Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 46 Latin America: Biologic Drug Product Manufacturing Market, by Country, 2021-2028 (USD Million)

8 Biotechnology Contract Manufacturing Market, by Scale of Operation
8.1 Introduction
Table 47 Biotechnology Contract Manufacturing Industry, by Scale of Operation, 2021-2028 (USD Million)
8.2 Commercial Operations
8.2.1 Increasing Approvals of Biologics to Support Market Growth
Table 48 Market for Commercial Operations, by Region, 2021-2028 (USD Million)
Table 49 North America: Market for Commercial Operations, by Country, 2021-2028 (USD Million)
Table 50 Europe: Market for Commercial Operations, by Country, 2021-2028 (USD Million)
Table 51 Asia-Pacific: Market for Commercial Operations, by Country, 2021-2028 (USD Million)
Table 52 Latin America: Market for Commercial Operations, by Country, 2021-2028 (USD Million)
8.3 Clinical Operations
8.3.1 Increasing Number of Clinical Trials for Targeted Therapies to Drive Market
Table 53 Market for Clinical Operations, by Region, 2021-2028 (USD Million)
Table 54 North America: Market for Clinical Operations, by Country, 2021-2028 (USD Million)
Table 55 Europe: Market for Clinical Operations, by Country, 2021-2028 (USD Million)
Table 56 Asia-Pacific: Market for Clinical Operations, by Country, 2021-2028 (USD Million)
Table 57 Latin America: Market for Clinical Operations, by Country, 2021-2028 (USD Million)

9 Biotechnology Contract Manufacturing Market, by Source
9.1 Introduction
Table 58 Biotechnology Contract Manufacturing Industry, by Source, 2021-2028 (USD Million)
9.2 Mammalian Expression Systems
9.2.1 Versatile Therapeutic Diversity to Drive Market
Table 59 Types of Mammalian Expression Systems
Table 60 Market for Mammalian Expression Systems, by Region, 2021-2028 (USD Million)
Table 61 North America: Market for Mammalian Expression Systems, by Country, 2021-2028 (USD Million)
Table 62 Europe: Market for Mammalian Expression Systems, by Country, 2021-2028 (USD Million)
Table 63 Asia-Pacific: Market for Mammalian Expression Systems, by Country, 2021-2028 (USD Million)
Table 64 Latin America: Market for Mammalian Expression Systems, by Country, 2021-2028 (USD Million)
9.3 Non-Mammalian Expression Systems
9.3.1 Increasing Demand for Biologics Vaccines to Support Market Growth
Table 65 Types of Microbial Expression Systems and Their Applications
Table 66 Market for Non-Mammalian Expression Systems, by Region, 2021-2028 (USD Million)
Table 67 North America: Market for Non-Mammalian Expression Systems, by Country, 2021-2028 (USD Million)
Table 68 Europe: Market for Non-Mammalian Expression Systems, by Country, 2021-2028 (USD Million)
Table 69 Asia-Pacific: Market for Non-Mammalian Expression Systems, by Country, 2021-2028 (USD Million)
Table 70 Latin America: Market for Non-Mammalian Expression Systems, by Country, 2021-2028 (USD Million)

10 Biotechnology Contract Manufacturing Market, by Molecule Type
10.1 Introduction
Table 71 Biotechnology Contract Manufacturing Industry, by Molecule Type, 2021-2028 (USD Million)
10.2 Monoclonal Antibodies
10.2.1 Growing Approvals for Mabs to Propel Market
Figure 28 Number of Approved Monoclonal Antibodies, 2010-2022
Table 72 Market for Monoclonal Antibodies, by Region, 2021-2028 (USD Million)
Table 73 North America: Market for Monoclonal Antibodies, by Country, 2021-2028 (USD Million)
Table 74 Europe: Market for Monoclonal Antibodies, by Country, 2021-2028 (USD Million)
Table 75 Asia-Pacific: Market for Monoclonal Antibodies, by Country, 2021-2028 (USD Million)
Table 76 Latin America: Market for Monoclonal Antibodies, by Country, 2021-2028 (USD Million)
10.3 Cell & Gene Therapies
10.3.1 Increasing Prevalence of Chronic Diseases to Drive Market
Table 77 Fda-Approved Car T-Cell Therapies
Table 78 Market for Cell & Gene Therapies, by Region, 2021-2028 (USD Million)
Table 79 North America: Market for Cell & Gene Therapies, by Country, 2021-2028 (USD Million)
Table 80 Europe: Market for Cell & Gene Therapies, by Country, 2021-2028 (USD Million)
Table 81 Asia-Pacific: Market for Cell & Gene Therapies, by Country, 2021-2028 (USD Million)
Table 82 Latin America: Market for Cell & Gene Therapies, by Country, 2021-2028 (USD Million)
10.4 Antibody-Drug Conjugates
10.4.1 Increasing Investments in Biologics to Support Market Growth
Table 83 Market for Antibody-Drug Conjugates, by Region, 2021-2028 (USD Million)
Table 84 North America: Market for Antibody-Drug Conjugates, by Country, 2021-2028 (USD Million)
Table 85 Europe: Market for Antibody-Drug Conjugates, by Country, 2021-2028 (USD Million)
Table 86 Asia-Pacific: Market for Antibody-Drug Conjugates, by Country, 2021-2028 (USD Million)
Table 87 Latin America: Market for Antibody-Drug Conjugates, by Country, 2021-2028 (USD Million)
10.5 Vaccines
10.5.1 Increasing Demand for Vaccines to Drive Market
Table 88 Nih Funding for Vaccine Research, 2018-2022 (USD Million)
Table 89 Market for Vaccines, by Region, 2021-2028 (USD Million)
Table 90 North America: Market for Vaccines, by Country, 2021-2028 (USD Million)
Table 91 Europe: Market for Vaccines, by Country, 2021-2028 (USD Million)
Table 92 Asia-Pacific: Market for Vaccines, by Country, 2021-2028 (USD Million)
Table 93 Latin America: Market for Vaccines, by Country, 2021-2028 (USD Million)
10.6 Therapeutic Peptides & Proteins
10.6.1 Increasing Number of Research Projects in Genomics to Support Market Growth
Table 94 Examples of Peptide Therapeutics
Table 95 Commercialized Recombinant Proteins Used in Medicine
Table 96 Market for Therapeutic Peptides & Proteins, by Region, 2021-2028 (USD Million)
Table 97 North America: Market for Therapeutic Peptides & Proteins, by Country, 2021-2028 (USD Million)
Table 98 Europe: Market for Therapeutic Peptides & Proteins, by Country, 2021-2028 (USD Million)
Table 99 Asia-Pacific: Market for Therapeutic Peptides & Proteins, by Country, 2021-2028 (USD Million)
Table 100 Latin America: Market for Therapeutic Peptides & Proteins, by Country, 2021-2028 (USD Million)
10.7 Other Molecule Types
Table 101 Market for Other Molecule Types, by Region, 2021-2028 (USD Million)
Table 102 North America: Market for Other Molecule Types, by Country, 2021-2028 (USD Million)
Table 103 Europe: Market for Other Molecule Types, by Country, 2021-2028 (USD Million)
Table 104 Asia-Pacific: Market for Other Molecule Types, by Country, 2021-2028 (USD Million)
Table 105 Latin America: Market for Other Molecule Types, by Country, 2021-2028 (USD Million)

11 Biotechnology Contract Manufacturing Market, by Therapeutic Area
11.1 Introduction
Table 106 Biotechnology Contract Manufacturing Industry, by Therapeutic Area, 2021-2028 (USD Million)
11.2 Oncology
11.2.1 Increased Approvals and Launch of Biologics for Oncology to Drive Market
Table 107 Market for Oncology, by Region, 2021-2028 (USD Million)
Table 108 North America: Market for Oncology, by Country, 2021-2028 (USD Million)
Table 109 Europe: Market for Oncology, by Country, 2021-2028 (USD Million)
Table 110 Asia-Pacific: Market for Oncology, by Country, 2021-2028 (USD Million)
Table 111 Latin America: Market for Oncology, by Country, 2021-2028 (USD Million)
11.3 Autoimmune Diseases
11.3.1 Rising Prevalence of Autoimmune Diseases to Drive Market
Table 112 Market for Autoimmune Diseases, by Region, 2021-2028 (USD Million)
Table 113 North America: Market for Autoimmune Diseases, by Country, 2021-2028 (USD Million)
Table 114 Europe: Market for Autoimmune Diseases, by Country, 2021-2028 (USD Million)
Table 115 Asia-Pacific: Market for Autoimmune Diseases, by Country, 2021-2028 (USD Million)
Table 116 Latin America: Market for Autoimmune Diseases, by Country, 2021-2028 (USD Million)
11.4 Metabolic Diseases
11.4.1 Increasing Prevalence of Metabolic Diseases to Drive Adoption of Biologics
Table 117 Market for Metabolic Diseases, by Region, 2021-2028 (USD Million)
Table 118 North America: Market for Metabolic Diseases, by Country, 2021-2028 (USD Million)
Table 119 Europe: Market for Metabolic Diseases, by Country, 2021-2028 (USD Million)
Table 120 Asia-Pacific: Market for Metabolic Diseases, by Country, 2021-2028 (USD Million)
Table 121 Latin America: Market for Metabolic Diseases, by Country, 2021-2028 (USD Million)
11.5 Cardiovascular Diseases
11.5.1 Development of New Treatment Options to Support Market Growth
Table 122 Market for Cardiovascular Diseases, by Region, 2021-2028 (USD Million)
Table 123 North America: Market for Cardiovascular Diseases, by Country, 2021-2028 (USD Million)
Table 124 Europe: Market for Cardiovascular Diseases, by Country, 2021-2028 (USD Million)
Table 125 Asia-Pacific: Market for Cardiovascular Diseases, by Country, 2021-2028 (USD Million)
Table 126 Latin America: Market for Cardiovascular Diseases, by Country, 2021-2028 (USD Million)
11.6 Neurology
11.6.1 High Burden of Neurological Disorders to Propel Market
Table 127 Market for Neurology, by Region, 2021-2028 (USD Million)
Table 128 North America: Market for Neurology, by Country, 2021-2028 (USD Million)
Table 129 Europe: Market for Neurology, by Country, 2021-2028 (USD Million)
Table 130 Asia-Pacific: Market for Neurology, by Country, 2021-2028 (USD Million)
Table 131 Latin America: Market for Neurology, by Country, 2021-2028 (USD Million)
11.7 Infectious Diseases
11.7.1 Rising Epidemic Outbreaks to Support Market Growth
Table 132 Market for Infectious Diseases, by Region, 2021-2028 (USD Million)
Table 133 North America: Market for Infectious Diseases, by Country, 2021-2028 (USD Million)
Table 134 Europe: Market for Infectious Diseases, by Country, 2021-2028 (USD Million)
Table 135 Asia-Pacific: Market for Infectious Diseases, by Country, 2021-2028 (USD Million)
Table 136 Latin America: Market for Infectious Diseases, by Country, 2021-2028 (USD Million)
11.8 Other Therapeutic Areas
Table 137 Market for Other Therapeutic Areas, by Region, 2021-2028 (USD Million)
Table 138 North America: Market for Other Therapeutic Areas, by Country, 2021-2028 (USD Million)
Table 139 Europe: Market for Other Therapeutic Areas, by Country, 2021-2028 (USD Million)
Table 140 Asia-Pacific: Market for Other Therapeutic Areas, by Country, 2021-2028 (USD Million)
Table 141 Latin America: Market for Other Therapeutic Areas, by Country, 2021-2028 (USD Million)

12 Biotechnology Contract Manufacturing Market, by Region
12.1 Introduction
Table 142 Biotechnology Contract Manufacturing Industry, by Region, 2021-2028 (USD Million)
12.2 North America
Figure 29 North America: Biotechnology Contract Manufacturing Industry Snapshot
Table 143 North America: Market, by Country, 2021-2028 (USD Million)
Table 144 North America: Market, by Service, 2021-2028 (USD Million)
Table 145 North America: Market, by Type, 2021-2028 (USD Million)
Table 146 North America: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 147 North America: Market, by Source, 2021-2028 (USD Million)
Table 148 North America: Market, by Molecule Type, 2021-2028 (USD Million)
Table 149 North America: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.2.1 US
12.2.1.1 Presence of Large Number of Fda-Approved Manufacturing Facilities to Favor Market Growth
Table 150 US: Biotechnology Contract Manufacturing Market, by Service, 2021-2028 (USD Million)
Table 151 US: Market, by Type, 2021-2028 (USD Million)
Table 152 US: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 153 US: Market, by Source, 2021-2028 (USD Million)
Table 154 US: Market, by Molecule Type, 2021-2028 (USD Million)
Table 155 US: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.2.2 Canada
12.2.2.1 Rising Government Funding for Drug Development to Support Market Growth
Table 156 Canada: Market, by Service, 2021-2028 (USD Million)
Table 157 Canada: Market, by Type, 2021-2028 (USD Million)
Table 158 Canada: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 159 Canada: Market, by Source, 2021-2028 (USD Million)
Table 160 Canada: Market, by Molecule Type, 2021-2028 (USD Million)
Table 161 Canada: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.2.3 Recession Impact
12.3 Europe
Table 162 Europe: Biotechnology Contract Manufacturing Market, by Country, 2021-2028 (USD Million)
Table 163 Europe: Market, by Service, 2021-2028 (USD Million)
Table 164 Europe: Market, by Type, 2021-2028 (USD Million)
Table 165 Europe: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 166 Europe: Market, by Source, 2021-2028 (USD Million)
Table 167 Europe: Market, by Molecule Type, 2021-2028 (USD Million)
Table 168 Europe: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.3.1 Germany
12.3.1.1 Rapidly Growing Pharmaceutical Market to Drive Market
Table 169 Germany: Biotechnology Contract Manufacturing Industry, by Service, 2021-2028 (USD Million)
Table 170 Germany: Market, by Type, 2021-2028 (USD Million)
Table 171 Germany: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 172 Germany: Market, by Source, 2021-2028 (USD Million)
Table 173 Germany: Market, by Molecule Type, 2021-2028 (USD Million)
Table 174 Germany: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.3.2 UK
12.3.2.1 Rising Investments in Drug Development to Favor Market Growth
Table 175 UK: Biotechnology Contract Manufacturing Market, by Service, 2021-2028 (USD Million)
Table 176 UK: Market, by Type, 2021-2028 (USD Million)
Table 177 UK: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 178 UK: Market, by Source, 2021-2028 (USD Million)
Table 179 UK: Market, by Molecule Type, 2021-2028 (USD Million)
Table 180 UK: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.3.3 France
12.3.3.1 Availability of Funds from Government and Private Organizations for Domestic Drug Development to Support Market Growth
Table 181 France: Market, by Service, 2021-2028 (USD Million)
Table 182 France: Market, by Type, 2021-2028 (USD Million)
Table 183 France: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 184 France: Market, by Source, 2021-2028 (USD Million)
Table 185 France: Market, by Molecule Type, 2021-2028 (USD Million)
Table 186 France: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.3.4 Italy
12.3.4.1 Rising Commercial Drug Development Pipeline to Drive Market
Table 187 Italy: Biotechnology Contract Manufacturing Market, by Service, 2021-2028 (USD Million)
Table 188 Italy: Market, by Type, 2021-2028 (USD Million)
Table 189 Italy: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 190 Italy: Market, by Source, 2021-2028 (USD Million)
Table 191 Italy: Market, by Molecule Type, 2021-2028 (USD Million)
Table 192 Italy: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.3.5 Spain
12.3.5.1 Rising R&D Expenditure to Propel Market
Table 193 Spain: Biotechnology Contract Manufacturing Industry, by Service, 2021-2028 (USD Million)
Table 194 Spain: Market, by Type, 2021-2028 (USD Million)
Table 195 Spain: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 196 Spain: Market, by Source, 2021-2028 (USD Million)
Table 197 Spain: Market, by Molecule Type, 2021-2028 (USD Million)
Table 198 Spain: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.3.6 Rest of Europe
Table 199 Rest of Europe: Biotechnology Contract Manufacturing Market, by Service, 2021-2028 (USD Million)
Table 200 Rest of Europe: Market, by Type, 2021-2028 (USD Million)
Table 201 Rest of Europe: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 202 Rest of Europe: Market, by Source, 2021-2028 (USD Million)
Table 203 Rest of Europe: Market, by Molecule Type, 2021-2028 (USD Million)
Table 204 Rest of Europe: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.3.7 Recession Impact
12.4 Asia-Pacific
Figure 30 Asia-Pacific: Market Snapshot
Table 205 Asia-Pacific: Market, by Country, 2021-2028 (USD Million)
Table 206 Asia-Pacific: Market, by Service, 2021-2028 (USD Million)
Table 207 Asia-Pacific: Market, by Type, 2021-2028 (USD Million)
Table 208 Asia-Pacific: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 209 Asia-Pacific: Market, by Source, 2021-2028 (USD Million)
Table 210 Asia-Pacific: Market, by Molecule Type, 2021-2028 (USD Million)
Table 211 Asia-Pacific: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.4.1 China
12.4.1.1 Low Manufacturing Cost and High Demand for Medicines to Favor Market Growth
Table 212 China: Biotechnology Contract Manufacturing Market, by Service, 2021-2028 (USD Million)
Table 213 China: Market, by Type, 2021-2028 (USD Million)
Table 214 China: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 215 China: Market, by Source, 2021-2028 (USD Million)
Table 216 China: Market, by Molecule Type, 2021-2028 (USD Million)
Table 217 China: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.4.2 Japan
12.4.2.1 Growing Demand for Biosimilars to Drive Growth
Table 218 Japan: Biotechnology Contract Manufacturing Industry, by Service, 2021-2028 (USD Million)
Table 219 Japan: Market, by Type, 2021-2028 (USD Million)
Table 220 Japan: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 221 Japan: Market, by Source, 2021-2028 (USD Million)
Table 222 Japan: Market, by Molecule Type, 2021-2028 (USD Million)
Table 223 Japan: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.4.3 South Korea
12.4.3.1 Increasing R&D Activities for Drug Development to Drive Market
Table 224 South Korea: Biotechnology Contract Manufacturing Market, by Service, 2021-2028 (USD Million)
Table 225 South Korea: Market, by Type, 2021-2028 (USD Million)
Table 226 South Korea: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 227 South Korea: Market, by Source, 2021-2028 (USD Million)
Table 228 South Korea: Market, by Molecule Type, 2021-2028 (USD Million)
Table 229 South Korea: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.4.4 India
12.4.4.1 Increasing Pharma R&D Activities and Government Funding for Biotechnology Industry to Support Market Growth
Table 230 India: Biotechnology Contract Manufacturing Industry, by Service, 2021-2028 (USD Million)
Table 231 India: Market, by Type, 2021-2028 (USD Million)
Table 232 India: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 233 India: Market, by Source, 2021-2028 (USD Million)
Table 234 India: Market, by Molecule Type, 2021-2028 (USD Million)
Table 235 India: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.4.5 Rest of Asia-Pacific
Table 236 Rest of Asia-Pacific: Biotechnology Contract Manufacturing Market, by Service, 2021-2028 (USD Million)
Table 237 Rest of Asia-Pacific: Market, by Type, 2021-2028 (USD Million)
Table 238 Rest of Asia-Pacific: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 239 Rest of Asia-Pacific: Market, by Source, 2021-2028 (USD Million)
Table 240 Rest of Asia-Pacific: Market, by Molecule Type, 2021-2028 (USD Million)
Table 241 Rest of Asia-Pacific: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.4.6 Recession Impact
12.5 Latin America
Table 242 Latin America: Market, by Country, 2021-2028 (USD Million)
Table 243 Latin America: Market, by Service, 2021-2028 (USD Million)
Table 244 Latin America: Market, by Type, 2021-2028 (USD Million)
Table 245 Latin America: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 246 Latin America: Market, by Source, 2021-2028 (USD Million)
Table 247 Latin America: Market, by Molecule Type, 2021-2028 (USD Million)
Table 248 Latin America: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.5.1 Brazil
12.5.1.1 Growing Pharmaceutical Industry to Drive Market
Table 249 Brazil: Biotechnology Contract Manufacturing Market, by Service, 2021-2028 (USD Million)
Table 250 Brazil: Market, by Type, 2021-2028 (USD Million)
Table 251 Brazil: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 252 Brazil: Market, by Source, 2021-2028 (USD Million)
Table 253 Brazil: Market, by Molecule Type, 2021-2028 (USD Million)
Table 254 Brazil: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.5.2 Rest of Latin America
Table 255 Rest of Latin America: Biotechnology Contract Manufacturing Industry, by Service, 2021-2028 (USD Million)
Table 256 Rest of Latin America: Market, by Type, 2021-2028 (USD Million)
Table 257 Rest of Latin America: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 258 Rest of Latin America: Market, by Source, 2021-2028 (USD Million)
Table 259 Rest of Latin America: Market, by Molecule Type, 2021-2028 (USD Million)
Table 260 Rest of Latin America: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.5.3 Recession Impact
12.6 Middle East & Africa
12.6.1 Growing Pharmaceuticals Industry to Support Market Growth
Table 261 Middle East & Africa: Biotechnology Contract Manufacturing Market, by Service, 2021-2028 (USD Million)
Table 262 Middle East & Africa: Market, by Type, 2021-2028 (USD Million)
Table 263 Middle East & Africa: Market, by Scale of Operation, 2021-2028 (USD Million)
Table 264 Middle East & Africa: Market, by Source, 2021-2028 (USD Million)
Table 265 Middle East & Africa: Market, by Molecule Type, 2021-2028 (USD Million)
Table 266 Middle East & Africa: Market, by Therapeutic Area, 2021-2028 (USD Million)
12.6.2 Recession Impact

13 Competitive Landscape
13.1 Introduction
Figure 31 Biotechnology Contract Manufacturing Market: Strategies Adopted by Key Players
13.2 Revenue Share Analysis
Figure 32 Revenue Analysis of Key Players, 2020-2022
13.3 Market Share Analysis
Figure 33 Biotechnology Contract Manufacturing Industry Share Analysis of Key Players, 2022
Table 267 Biotechnology Contract Manufacturing Industry: Degree of Competition
13.4 Company Evaluation Matrix
13.4.1 Stars
13.4.2 Emerging Leaders
13.4.3 Pervasive Players
13.4.4 Participants
Figure 34 Biotechnology Contract Manufacturing Industry: Company Evaluation Matrix for Key Players, 2022
13.5 Competitive Benchmarking
13.5.1 Company Footprint Analysis
Table 268 Company Footprint Analysis
13.5.2 Company Footprint Analysis, by Molecule Type
Table 269 Molecule Type Footprint Analysis of Companies
13.5.3 Company Footprint Analysis, by Region
Table 270 Regional Footprint Analysis of Companies
13.6 Company Evaluation Matrix for Startups/SMEs
13.6.1 Progressive Companies
13.6.2 Starting Blocks
13.6.3 Responsive Companies
13.6.4 Dynamic Companies
Figure 35 Market: Company Evaluation Matrix for Startups/SMEs, 2022
13.7 Competitive Benchmarking of Startup/SME Players
Table 271 Market: Detailed List of Key Startup/SME Players
Table 272 Market: Competitive Benchmarking of Startups/SME Players
13.8 Competitive Scenario and Trends
13.8.1 Deals
Table 273 Market: Deals, January 2020-July 2023
13.8.2 Other Developments
Table 274 Market: Other Developments, January 2020-July 2023

14 Company Profiles
Business Overview, Products/Solutions/Services Offered, Recent Developments, Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, Weakness/Competitive Threats
14.1 Key Players
14.1.1 Lonza
Table 275 Lonza: Business Overview
Figure 36 Lonza: Company Snapshot (2022)
14.1.2 Thermo Fisher Scientific Inc.
Table 276 Thermo Fisher Scientific Inc.: Business Overview
Figure 37 Thermo Fisher Scientific Inc.: Company Snapshot (2022)
14.1.3 Wuxi Biologics
Table 277 Wuxi Biologics: Business Overview
Figure 38 Wuxi Biologics: Company Snapshot (2022)
14.1.4 Catalent, Inc.
Table 278 Catalent, Inc.: Business Overview
Figure 39 Catalent, Inc.: Company Snapshot (2022)
14.1.5 Samsung Biologics
Table 279 Samsung Biologics: Business Overview
Figure 40 Samsung Biologics: Company Snapshot (2022)
14.1.6 Boehringer Ingelheim International GmbH
Table 280 Boehringer Ingelheim International GmbH: Business Overview
Figure 41 Boehringer Ingelheim International GmbH: Company Snapshot (2022)
14.1.7 Fujifilm Holdings Corporation
Table 281 Fujifilm Holdings Corporation: Business Overview
Figure 42 Fujifilm Holdings Corporation: Company Snapshot (2022)
14.1.8 Abbvie Inc.
Table 282 Abbvie Inc.: Business Overview
Figure 43 Abbvie Inc.: Company Snapshot (2022)
14.1.9 Eurofins Scientific
Table 283 Eurofins Scientific: Business Overview
Figure 44 Eurofins Scientific: Company Snapshot (2022)
14.1.10 Genscript Biotech Corporation
Table 284 Genscript Biotech Corporation: Business Overview
Figure 45 Genscript Biotech Corporation: Company Snapshot (2022)
14.1.11 Agc Inc.
Table 285 Agc Inc.: Business Overview
Figure 46 Agc Inc.: Company Snapshot (2022)
14.1.12 Merck KGaA
Table 286 Merck KGaA: Business Overview
Figure 47 Merck KGaA: Company Snapshot (2022)
14.1.13 Jsr Corporation
Table 287 Jsr Corporation: Business Overview
Figure 48 Jsr Corporation: Company Snapshot (2022)
14.2 Other Players
14.2.1 Stelis
14.2.2 Recipharm Ab
14.2.3 Emergent
14.2.4 Shanghai Fosun Pharmaceutical Co. Ltd.
14.2.5 Lotte Biologics
14.2.6 Hepalink Group
14.2.7 Curia Global, Inc.
14.2.8 Jrs Pharma
14.2.9 Minapharm Pharmaceuticals
14.2.10 Rentschler Biopharma SE
14.2.11 Avid Bioservices, Inc.
14.2.12 Abzena Ltd.
14.2.13 Polyplus Transfection
14.2.14 Midas Pharma GmbH
14.2.15 Mabplex International Co. Ltd.
14.2.16 Asahi Kasei Corporation
Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, Weakness/Competitive Threats)* Might Not be Captured in Case of Unlisted Companies

15 Appendix
15.1 Discussion Guide
15.2 Knowledgestore: The Subscription Portal
15.3 Customization Options

Executive Summary

Companies Mentioned

  • Abbvie Inc.
  • Abzena Ltd.
  • Agc Inc.
  • Asahi Kasei Corporation
  • Avid Bioservices, Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Curia Global, Inc.
  • Emergent
  • Eurofins Scientific
  • Fujifilm Holdings Corporation
  • Genscript Biotech Corporation
  • Hepalink Group
  • Jrs Pharma
  • Jsr Corporation
  • Lonza
  • Lotte Biologics
  • Mabplex International Co. Ltd.
  • Merck KGaA
  • Midas Pharma GmbH
  • Minapharm Pharmaceuticals
  • Polyplus Transfection
  • Recipharm Ab
  • Rentschler Biopharma SE
  • Samsung Biologics
  • Shanghai Fosun Pharmaceutical Co. Ltd.
  • Stelis
  • Thermo Fisher Scientific Inc.
  • Wuxi Biologics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages324
PublishedSeptember 2023
Forecast Period2023 - 2028
Estimated Market Value ( USD ) in 2023 $ 16.6 Billion
Forecasted Market Value ( USD ) by 2028 $ 24.8 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Global Biotechnology Market by Technology (Cell-Based Assays, Chromatography, DNA Sequencing), Application (Bioinformatics, Food & Agriculture, Health) - Cumulative Impact of High Inflation - Forecast 2023-2030 - Product Image

Global Biotechnology Market by Technology (Cell-Based Assays, Chromatography, DNA Sequencing), Application (Bioinformatics, Food & Agriculture, Health) - Cumulative Impact of High Inflation - Forecast 2023-2030

  • Report
  • 241 Pages
  • Global
From
Biotechnology for the Non-Biotechnologist Training Course (December 2, 2024) - Product Image

Biotechnology for the Non-Biotechnologist Training Course (December 2, 2024)

  • Conference
  • 5 Days
  • Global
Global Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), End-user, and Region - Forecast to 2028 - Product Image

Global Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), End-user, and Region - Forecast to 2028

  • Report
  • 263 Pages
  • Global
From
Global Tangential Flow Filtration Market by Product (Systems, Membrane Filters), Material (PES, PVDF, PTFE), Technique (Ultrafiltration, Microfiltration), Application (Final Product Processing, Cell Separation), End User, Region - Forecast to 2028 - Product Image

Global Tangential Flow Filtration Market by Product (Systems, Membrane Filters), Material (PES, PVDF, PTFE), Technique (Ultrafiltration, Microfiltration), Application (Final Product Processing, Cell Separation), End User, Region - Forecast to 2028

  • Report
  • 343 Pages
  • Global
From
Single Use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred Tank, Wave Induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User - Global Forecast to 2030 - Product Image

Single Use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred Tank, Wave Induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User - Global Forecast to 2030

  • Report
  • 251 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.